NYSE:ELN - Elan Stock Price, Forecast & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Elan Co. Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileEarningsFinancialsHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Elan Corporation Ltd (Elan), formerly Elan Corporation, plc, is a biotechnology company. The Company is focused on discovering and developing advanced therapies in neurodegenerative and autoimmune diseases. On February 6, 2013, the Company announced that it has entered into an asset purchase agreement with Biogen Idec to transfer to Biogen Idec all Tysabri IP and other assets related to Tysabri. Read More… Industry, Sector and Symbol Stock Exchange NYSE Industry N/A Sub-IndustryN/A SectorN/A Current SymbolNYSE:ELN Previous Symbol CUSIPN/A CIK737572 Webhttp://www.elan.com/ Phone+353-1-7094000Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Receive ELN News and Ratings via Email Sign-up to receive the latest news and ratings for ELN and its competitors with MarketBeat's FREE daily newsletter. Elan (NYSE:ELN) Frequently Asked Questions What is Elan's stock symbol? Elan trades on the New York Stock Exchange (NYSE) under the ticker symbol "ELN." Has Elan been receiving favorable news coverage? News stories about ELN stock have been trending extremely negative this week, InfoTrie reports. The research firm rates the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Elan earned a news sentiment score of -4.5 on InfoTrie's scale. They also gave news coverage about the biotechnology company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the near future. View News Stories for Elan. What other stocks do shareholders of Elan own? Based on aggregate information from My MarketBeat watchlists, some companies that other Elan investors own include La Jolla Pharmaceutical (LJPC), RealReal (REAL), Sarepta Therapeutics (SRPT), SVMK (SVMK), Chewy (CHWY), Uber Technologies (UBER), Slack (WORK), Altaba (AABA), Century Aluminum (CENX) and eBay (EBAY). What is Elan's official website? The official website for Elan is http://www.elan.com/. How can I contact Elan? Elan's mailing address is Treasury Building Grand Canal Street Lower, DUBLIN, 2, Ireland. The biotechnology company can be reached via phone at +353-1-7094000. MarketBeat Community Rating for Elan (NYSE ELN)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 94 (Vote Outperform)Underperform Votes: 114 (Vote Underperform)Total Votes: 208MarketBeat's community ratings are surveys of what our community members think about Elan and other stocks. Vote "Outperform" if you believe ELN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ELN will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/26/2020 by MarketBeat.com StaffFeatured Article: Trading Stocks - What are percentage gainers?